NHS Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Net Income	20.93	20.22	37.94	3.72	-33.49	26.8
Loss (Gain) From Sale of Investments	-5.47	-4.83	-23.94	7.62	46.9	-15.21
Other Operating Activities	-	-	-	-	-	0
Change in Accounts Receivable	-4.45	0.18	2.15	-3.18	-0.73	1.79
Change in Accounts Payable	5.3	-0.37	3.35	-0.71	-3.2	4.38
Change in Other Net Operating Assets	-91.74	-8.31	8.72	-44.5	-48.38	99.52
Operating Cash Flow	-76.7	3.62	21.1	-5.85	-48.69	104.23
Operating Cash Flow Growth	-	-82.84%	-	-	-	392.49%
Long-Term Debt Issued	-	29.5	28	66	26.5	-
Long-Term Debt Repaid	-	-12	-50.5	-46	-	-10.5
Net Debt Issued (Repaid)	40.5	17.5	-22.5	20	26.5	-10.5
Issuance of Common Stock	70.18	11.82	30.56	45.83	38.7	-
Repurchase of Common Stock	-	-	-	-	-	-58.77
Common Dividends Paid	-33.55	-32.92	-28.78	-23.38	-18.02	-16.26
Dividends Paid	-33.55	-32.92	-28.78	-23.38	-18.02	-16.26
Other Financing Activities	-0.39	-	-	-36	-	-
Financing Cash Flow	76.74	-3.6	-20.73	6.45	47.18	-104.53
Net Cash Flow	0.04	0.02	0.38	0.6	-1.51	-0.3
Cash Interest Paid	3.09	2.71	3.33	2.91	0.84	0.45
Levered Free Cash Flow	10.8	9.15	13.75	3.1	5.19	12.57
Unlevered Free Cash Flow	14.22	12.4	17.51	8.39	6.44	13.89
Change in Working Capital	-92.16	-11.77	7.1	-17.19	-62.1	92.64

SEC Filings: 10-K · 10-Q